NCT03830164View on ClinicalTrials.gov

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

November 2, 2022

Study Completion Date

November 2, 2022

Conditions

Male Erectile DisorderProstate AdenocarcinomaErectile Dysfunction, CTCAEImpotence

Interventions

DRUG

Atorvastatin

Given PO

DRUG

Pentoxifylline

Given PO

DIETARY_SUPPLEMENT

Vitamin E Compound

Given PO

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03830164 - Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer | Biotech Hunter | Biotech Hunter